GIP: Shows similar cancer risk reduction potential, likely due to its weight loss, insulin sensitivity, and anti-inflammatory effects
Their anti-inflammatory and immune-modulatory properties have long suggested broader effects. Dr Eleonora Teplinsky, the head of breast and gynaecologic medical oncology at Valley Health System in New Jersey, who also was not involved with the research, said the evidence was not clear yet as to whether the potential benefits of weight-loss drugs in the fight against cancer were just as a result of weight loss or due to other factors
Proteomics 14 , 14891500 (2015)
th Edition) 31 HasanuzzamanM.BhuyanM
Frontiers in endocrinology , 2 , 32
Many people start to see weight loss within the first 4 to 8 weeks, especially as they move into higher doses